Toggle menu
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.

Albert Bourla: Difference between revisions

From ProleWiki, the proletarian encyclopedia
More languages
(Created page with "{{Infobox person | name = Albert Bourla | native_name = Άλμπερτ Μπουρλά | birth_name = Άλμπερτ Μπουρλά<ref>{{Citation|title-url=http://eklogesapps.ypes.gr/eterodimotes/ETERODHMOTES3/wizard_search.asp | title=ΥΠΕΣ - ΔΙΕΥΘΥΝΣΗ ΗΛΕΚΤΡΟΝΙΚΗΣ ΔΙΑΚΥΒΕΡΝΗΣΗΣ Father's name:ΜΩΥΣ | trans-title=MINISTRY - DIRECTORATE OF ELECTRONIC GOVERNANCE|access-date=2020-11-09 | archive-date=2020-...")
 
(Document an honorary doctorate being given to Albert.)
Line 10: Line 10:
}}
}}


'''Albert Bourla''' is a Philosopher, Veterinary Doctor, and the [[Chief Executive Officer]] of [[Pfizer Inc.]]


'''Albert Bourla''' is a Philosopher, Veterinary Doctor, and the [[Chief Executive Officer]] of [[Pfizer Inc.]]
 
In January 7 2022, Professor Uri Sivan, the President of the [[Israel Institute of Technology]], awarded Albert an honorary doctorate in a graduation ceremony of 1,869 Technion undergraduates;<ref name='Techion Award'>{{Citation|title=Technion Awards Honorary Doctorate to Pfizer Chairman and CEO Dr. Albert Abraham Bourla|title-url=https://www.technion.ac.il/en/2022/07/bourla-honorary-doctorate/|publisher=Israel Institute of Technology}}</ref> for "developing a safe and effective vaccine against [[COVID-19]]."<ref name='Techion Award' />


==References==
==References==
<references />
<references />

Revision as of 11:04, 15 September 2022

Albert Bourla

Άλμπερτ Μπουρλά
Born
Άλμπερτ Μπουρλά[1]

(1961-10-21) October 21, 1961 (age 63)
Thessaloniki, Greece
NationalityGreek-Statesian
Field of studyPhilosophy and Veterinary Medicine


Albert Bourla is a Philosopher, Veterinary Doctor, and the Chief Executive Officer of Pfizer Inc.


In January 7 2022, Professor Uri Sivan, the President of the Israel Institute of Technology, awarded Albert an honorary doctorate in a graduation ceremony of 1,869 Technion undergraduates;[2] for "developing a safe and effective vaccine against COVID-19."[2]

References